FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

China-linked green group training US judges draws fresh heat as foreign ties fuel pressure at home

Mamdani gets roasted after telling sweltering New Yorkers to set ACs to 78 degrees: ‘Commie’

Thanks to Climate Panic, It’s 100 Degrees Inside a ‘Flagship’ Hospital Building – This Is What Leftists Want for Us (but Not Themselves)

WATCH: Trump Holds Conversation With AI Teddy Roosevelt, Gets Fresh Encouragement That He’s on the Right Path

America’s housing market could run out of something more important than homes

How Iran attacks are forcing the Pentagon to rethink its decades-old Middle East base strategy

Baby Beaten Nearly to Death by Children, 4 and 6, as Sitter Gives Most Nauseating Excuse We’ve Ever Heard

Ukraine’s 40-day missile and drone blitz heaps pressure and pain on Putin

DeSantis announces plans to use new state law to target dozens of alleged terrorist groups

Acting AG Todd Blanche says Newsom’s DOJ claims are not ‘grounded in fact’

Mexican national sentenced in border child smuggling case involving THC-laced candy

Virginia officer placed on administrative leave after malicious wounding charge tied to off duty incident

Two arrested at Costco after alleged fraudulent credit card shopping spree

Russian missile attack on Kyiv collapses apartment building, trapping residents

Wild video captures apartment complex electrical room explosion as firefighters investigate smoke call

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”